tiprankstipranks
Advertisement
Advertisement
Delcath: Buy Rating Reiterated as CHOPIN Data and Commercial Execution Support Unchanged $30 Price Target
PremiumRatingsDelcath: Buy Rating Reiterated as CHOPIN Data and Commercial Execution Support Unchanged $30 Price Target
19d ago
DCTH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
DCTH Upcoming Earnings Report: What to Expect?
21d ago
Delcath Systems price target raised to $17 from $16 at BTIG
Premium
The Fly
Delcath Systems price target raised to $17 from $16 at BTIG
1M ago
Delcath Systems presents new data on M-PHP at ESMO
PremiumThe FlyDelcath Systems presents new data on M-PHP at ESMO
4M ago
Delcath Systems reports Q1 EPS (3c), consensus (9c)
Premium
The Fly
Delcath Systems reports Q1 EPS (3c), consensus (9c)
4M ago
Delcath Systems backs FY26 revenue view at least $100M, consensus $102.69M
Premium
The Fly
Delcath Systems backs FY26 revenue view at least $100M, consensus $102.69M
4M ago
Delcath Highlights CHOPIN Phase 2 Results in Uveal Melanoma
PremiumCompany AnnouncementsDelcath Highlights CHOPIN Phase 2 Results in Uveal Melanoma
6M ago
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
Premium
The Fly
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
6M ago
Delcath Systems: Procedure-Driven Growth, Pricing Power, and CHOPIN Trial Catalysts Support Buy Rating
Premium
Ratings
Delcath Systems: Procedure-Driven Growth, Pricing Power, and CHOPIN Trial Catalysts Support Buy Rating
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100